IncFact
Company Profiles: Revenue, Growth, Competition

Juno Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Juno Therapeutics

Access the complete profile.

Juno Therapeutics Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees500 - 1,000Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Address400 Dexter Avenue North
Suite 1200
Seattle, WA 98109

Note: Revenues for privately held companies are statistical evaluations.


Juno Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Juno Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Juno Therapeutics Annual Revenue and Growth Rate

Juno Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $100 - $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Juno Therapeutics's revenues are gauged from an analysis of company filings.



Juno Therapeutics's Income Statement (based on Industry Averages)

Juno Therapeutics P&L$ Millions
Revenue (Sales) Juno Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Investor Activity

Juno Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
October 5, 2017 1 100%$31 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Juno Therapeutics is developing and marketing. Juno Therapeutics doesn't have any recent trademark applications, indicating Juno Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
KONFIRI
Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
05/13/2020
BREYANZI
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
08/07/2019
LISO-CEL
Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
12/08/2017

See all trademarks and details in the Full Report.


Market Share of Juno Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Juno Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Juno Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
FRED HUTCHINSON CANCER CENTERSeattle, WA100 
ADAPTIVE BIOTECHNOLOGIESSeattle, WA14 
ALLEN INSTITUTESeattle, WA13 
JUNO THERAPEUTICSSeattle, WA13 
SANA BIOTECHNOLOGYSeattle, WA9 
ULTRA SAFE NUCLEARSeattle, WA5 




Future Competition: Juno Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Juno Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Juno Therapeutics Competitors